In this respect, only the GSEA signature for the JAK/STAT pathway showed a confidence rate above 95% and was significantly enriched in patients with JAK/STAT pathway mutations compared to the rest of T-ALL/LBL patients (Fig. 1c). Here, SOAT1 is linked to acute lymphoblastic leukemia.